BBVA USA’s Lam Research LRCX Stock Holding History

BBVA USA’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$9K	Hold	150	–	–	﹤0.01%	836
2021 Q2	$10K	Buy	+150	New	+$9.47K	﹤0.01%	863

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BBVA USA's LRCX Position: Q3 2021 in Review

BBVA USA held its Lam Research (LRCX) position steady in Q3 2021 at 150 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

BBVA USA first reported a position in LRCX in Q2 2021 and has held it in 2 quarters since. The position peaked at $10K in Q2 2021. 1,297 funds tracked by Wall St. Rank hold LRCX as of Q3 2021.

BBVA USA held 150 shares of Lam Research worth $9K as of Q3 2021.
BBVA USA left its Lam Research share count unchanged in Q3 2021.
Lam Research made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #836 holding.
BBVA USA first reported a position in Lam Research in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Lam Research position peaked at $10K in Q2 2021.
1,297 funds tracked by Wall St. Rank held Lam Research as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.